Eli Lilly (NYSE: LLY) stock has been a top performer thanks to runaway sales of its diabetes-turned-weight-management treatment. Despite nearly doubling over the past 12 months, Eli Lilly stock ...

Just like their two Super Bowl matchups, Tom Brady thought he got in the final word only for Eli Manning to one-up him. Brady, who went 0-2 against the Giants on the NFL’s biggest stage ...

Eli Lilly stock is way up over the past year, but analysts who follow the company think it still has more upside. Sales of Eli Lilly's weight-management treatment are soaring and could climb much ...

Scott Olson / Staff / Getty Images Eli Lilly is set to report earnings Tuesday as investors and analysts expect weight-loss drug demand to continue boosting the company's revenue and profits.

Eli Lilly's weight loss-related drug Zepbound could potentially be used to reduce the severity of sleep apnea in adults with obesity, according to a recent study. Results of a phase three ...

, opens new tab and purchasers of its insulin drugs that would have capped prices and provided $13.5 million to resolve claims that the company inflated the drugs' cost has fallen apart, after an ...

Managed by Grow Therapy. Your call or email may go to a representative. Dr. McCullough, a seasoned therapist, holds a Ph.D. in Counseling Psychology, bringing a wealth of expertise to her practice.

The Nebraska Cornhuskers had a plethora of visitors on campus during the Red-White spring game, including Ei Johnson. Johnson is a 2026 wide receiver and tight end at Westside High School in Omaha ...

Warning! GuruFocus has detected 8 Warning Signs with GLW. On April 30, 2024, Eli Lilly and Co (NYSE:LLY) announced its first-quarter financial results for 2024, revealing a significant increase in ...

Another new indication for injectable GLP-1 drugs: better sleep. On Wednesday, drugmaker Eli Lilly announced positive results from a large, phase-3 clinical trial, testing Zepbound (a drug name ...